December 2024

Zydus Life sciences Limited has received final approval from the United States Food and Drug Administration to manufacture Lidocaine and Prilocaine Cream USP.

The U.S. Food and Drug Administration approved Ryoncil remestemcel-L-rknd, an allogeneic donor bone marrow-derived mesenchymal stromal cell therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease SR-aGVHD in pediatric patients 2 months of age and older.

Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. , has received approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application for Lisdexamfetamine Dimesylate Chewable Tablets.

Sun Pharma Advanced Research Company Ltd announced the signing of a binding Letter of Intent with the University of California, San Francisco, through the office of OTMA, and Tiller Therapeutics Inc. to license SPARC’s rights in the joint intellectual property held between SPARC and UCSF for pre-clinical oncology asset along with associated IP. The LOI outlines the key terms of license and rights for development and commercialization by Tiller.

M.Pharmor MSc; Integrated Magneto-Acousto-Dielectrophoresis based Microfluidics for the Sorting of Bovine Spermatozoa under Consortium 2 on Bovine Sex semen sorting Technology.

Department Pharmacology, Pharmaceutics, Pharmacognosy, Candidate should have completed their Ph.D. in their relevant discipline.

Masters Degree in Pharmacognosy, Botany from a recognized University or equivalent. Working expertise in pharmacognostical and anatomical techniques. Plant based Drug standardization in the field of medicinal plants. 

Standardization of spices and spice-based products. Candidate must have completed a Master of Pharmacy.

Life sciences with specialization in Molecular biology, Microbial genetics, Cell biology or Genetics from a recognized University.